Reports

Assess the impact of the COVID-19 pandemic on IRS customer service operations and evaluate the development of the IRS’s comprehensive customer service strategy. 

The Defense Intelligence Agency Office of the Inspector General initiated an evaluation of the Agency's use of Reserve military intelligence capabilities across the Defense Intelligence Enterprise.  Our objective is to assess the effectiveness of Agency’s use of Reserve military intelligence forces for the delivery and integration of Reserve capabilities across the Defense Intelligence Enterprise in peacetime and during crisis and contingency operations.  Through this evaluation effort, we will examine the use of Reserve military intelligence capabilities during the COVID-19 pandemic.

In response to the Under Secretary of Defense for Intelligence and Security's initiative to professionalize the analysis workforce within the Department of Defense (DoD), the Defense Intelligence Agency (DIA) Office of the Inspector General initiated an evaluation to assess the Agency's effectiveness in serving as the All-Source Analyst Professional Certification Program management lead.  We will assess the effectiveness of the DIA’s efforts to administer, implement, and oversee the program in accordance with DoD, Intelligence Community, Agency, and national accreditation policies and standards. As a part of this evaluation effort, we will also examine the impact of the COVID-19 pandemic on DIA's ability to provide the DoD analysis workforce with continuous opportunities to attain the Certified Defense All-Source Analyst-I professional credential.

The National Reconnaissance Office (NRO) Office of Inspector General (OIG) is conducting an evaluation of the NRO’s implementation of section 3610 authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act.  The objectives are to evaluate the NRO’s implementation of section 3610 authorized by the CARES Act and to identify preliminary impacts to NRO mission.

As required by section 8L of the Inspector General Act of 1978, as amended, the Inspectors General for the Department of Defense, Department of State, and USAID work together to report quarterly to Congress on every overseas contingency operation’s progress and corresponding oversight activities.  Starting in the second quarter of fiscal year 2020, these quarterly reports include reporting on the COVID-19 outbreaks in Afghanistan, Syria, Iraq, and the Philippines, as well as the U.S. government response to them.

In accordance with the CARES Act, Section 3610, “Federal Contractor Authority,” March 27, 2020 we will evaluate DIA’s implementation of Section 3610. Our objective is to determine whether DIA’s contractor reimbursements were appropriate and governed by policies and procedures that met the Act’s requirements.

The objective is to assess whether American Samoa used Coronavirus Relief Fund payment proceeds in accordance with 601(d) of the Social Security Act, as amended, (42 U.S.C. 801(d)), Treasury's Coronavirus Relief Guidance For State, Territorial, Local, and Tribal Governments, and Treasury's Coronavirus Relief Fund Frequently Asked Questions. 

The Families First Coronavirus Response Act provided $64 million in additional resources for COVID-19 response activities through the Indian Health Service (IHS) and requires coverage, without cost-sharing, for COVID-19 testing for American Indians/Alaska Natives, who receive health services. The Paycheck Protection Program and Health Care Enhancement Act provided $750 million for COVID-19 testing and testing-related services through IHS. From these two Acts, funding for COVID-19 testing to urban Indian organizations total $53 million and funding to IHS Federal health programs and Tribal health programs total $611 million. We will audit IHS's allocation and utilization of funding to urban Indian organizations, IHS Federal health programs and Tribal health programs. Specifically, our objectives will be to determine whether: (1) IHS allocated the COVID-19 funds to ensure that testing supplies were available to meet community needs, and (2) COVID-19 funds were used by IHS and grantees for testing, including other testing-related services, in accordance with Federal requirements.

 This work will provide details of the effectiveness of CMS controls over its Accelerated and Advance Payment Program (AAP) payments to providers and payment recovery. We will obtain data and meet with program officials to understand CMS's eligibility determination process for AAP payments and the steps CMS will have taken to recover such funds in compliance with the CARES Act and other Federal requirements. The objectives of our work will be to determine whether CMS made AAP payments to eligible providers and implemented controls to recover the AAP payments in compliance with the CARES Act and other Federal requirements. We will also evaluate a select group of providers to determine whether they were eligible for AAP payments, and their efforts to repay CMS in compliance with the CARES Act and other Federal requirements.

As a result of the coronavirus disease 2019 (COVID-19) pandemic, Medicaid provider enrollment through State Medicaid agencies has been expedited under the SSA §1135 Authority to Waive Requirements during National Emergencies. Rapid loosening of established provider screening and background check requirements may limit a State's ability to identify providers who are not eligible to participate in Medicaid. Our objective is to determine whether the State agency and providers complied with Federal and State requirements for newly enrolled providers under the national emergency declaration and if the State established tracking controls for these providers as well as giving providers adequate guidance on waived enrollment requirements.

As information on rates of infection and outcomes for the ongoing COVID-19 pandemic emerges, numerous reports document racial, ethnic, and socioeconomic disparities in rates of adverse outcomes from COVID-19, including death. This study will review the locations of hospitals that received Provider Relief Funds, with particular attention to hospitals located in communities of color and economically disadvantaged communities that were disproportionately impacted by adverse COVID-19 outcomes (i.e., hospitalization or death).

With emerging information on rates of infection and outcomes for the ongoing coronavirus disease 2019 (COVID-19), numerous reports document a disproportionate burden of infection and deaths among communities of color and economically disadvantaged communities. This study will examine data that the Centers for Disease Control and Prevention (CDC) collects and maintains that can be used to assess racial, ethnic, and socioeconomic disparities in COVID-19 cases and outcomes, as well as how CDC uses those data as part of its activities to address the COVID-19 pandemic. We will also examine CDC's lessons learned about how to best protect communities of color and economically disadvantaged communities in future public health emergencies.